Researchers at Harvard University’s Dana-Farber Cancer Institute released a study that reveals that a chemical found in cannabis has demonstrated “significant therapy potential” for pancreatic cancer, according to Yahoo News.
The study was published in the journal Frontiers of Oncology on July 23. Pancreatic cancer makes up just 3% of all cancer in the US, but has a one-year survival rate of 20%. Pancreatic cancer victims have a five-year survival rate of less than 8%. This cancer is thought to be the leading cause of cancer-related death by 2020.
The drug called FBL-03G comes from cannabis “flavonoid.” Cannabis flavonoids have long been thought to have therapeutic potential, but the chemical makes up just 0.14% of the plant. This means that researchers and producers need to use an entire field of cannabis to just get enough of the chemical to use to heal.
Wilfred Ngwa, PhD, an assistant professor at Harvard and one of the study’s researcher, said, “The most significant conclusion is that tumor-targeted delivery of flavonoids, derived from cannabis, enabled both local and metastatic tumor cell kill, significantly increasing survival from pancreatic cancer. This has major significance, given that pancreatic cancer is particularly refractory to current therapies.”